Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

FATE.US Logo

FATE.US - Current Price

$1.07

Company Information

▼
Company Name
Fate Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US31189P1021
CIK: 0001434316
CUSIP: 31189P102
Currency: USD
Full Time Employees: 181
Phone: 858 875 1800
Website: https://www.fatetherapeutics.com
Fiscal Year End: December
IPO Date: Oct 01, 2013
Description:

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Address:

12278 Scripps Summit Drive, San Diego, CA, United States, 92131

Directors & Officers

▼
Name Title Year Born
Dr. Bahram Valamehr M.B.A., Ph.D. President, CEO & Director 1977
Ms. Cindy R. Tahl J.D. Chief Legal & Compliance Officer and Corporate Secretary 1973
Mr. Kamal Adawi M.S., MBA Chief Financial Officer 1979
Ms. Jessica Francis Vice President Of Human Resources & Operations NA
Mr. Victor Hong Vice President of Corporate Development & Finance NA
Mr. Andrew Henry Senior Vice President of Clinical Operations 1964
Dr. Tunde Babalola Ph.D. Senior Vice President of Technical Operations NA
Dr. Yu Cai J.D., Ph.D. Head of Intellectual Property & Assistant General Counsel NA
Ms. Kate Duvall Corporate Controller NA

Shares Statistics

▼
Shares Outstanding: 115.35M
Shares Float: 100.82M
% Insiders: 151.90%
% Institutions: 7,929.20%
Short % Float: 8.72%

Valuation Metrics

▼
Enterprise Value: $-15.06M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $123.43M
EBITDA: $-145.34M
PEG Ratio: $0.00
Book Value: $2.03
Earnings/Share: $-1.36
Profit Margin: 0.00%
Operating Margin: -1,995.12%
ROA (TTM): -23.85%
ROE (TTM): -52.35%
Revenue (TTM): $7.14M
Revenue/Share (TTM): $0.06
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -43.40%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 -0.27 N/A 10,000.00%
Sep 30, 2025 -0.27 -0.30 N/A 1,000.00%
Jun 30, 2025 -0.29 -0.34 N/A 1,470.59%
Mar 31, 2025 -0.32 -0.38 N/A 1,565.63%
Dec 31, 2024 -0.44 -0.42 N/A -382.26%
Sep 30, 2024 -0.40 -0.41 N/A 295.97%
Jun 30, 2024 -0.33 -0.48 N/A 3,125.00%
Mar 31, 2024 -0.47 -0.49 N/A 408.16%
Dec 31, 2023 -0.45 -0.52 N/A 1,346.15%
Sep 30, 2023 -0.46 -0.57 N/A 1,929.82%
Jun 30, 2023 -0.54 -0.59 N/A 847.46%
Mar 31, 2023 -0.19 -0.62 N/A 6,935.48%
Dec 31, 2022 -0.58 -0.86 N/A 3,255.81%
Sep 30, 2022 -0.86 -0.89 N/A 337.08%
Jun 30, 2022 -0.79 -0.83 N/A 481.93%
Mar 31, 2022 -0.68 -0.77 N/A 1,168.83%
Dec 31, 2021 -0.72 -0.67 N/A -746.27%
Sep 30, 2021 -0.45 -0.58 N/A 2,241.38%
Jun 30, 2021 -0.58 -0.53 N/A -943.40%
Mar 31, 2021 -0.48 -0.43 N/A -1,162.79%
Dec 31, 2020 -0.61 -0.39 N/A -5,641.03%
Sep 30, 2020 -0.68 -0.36 N/A -8,888.89%
Jun 30, 2020 -0.35 -0.27 N/A -2,962.96%
Mar 31, 2020 -0.44 -0.39 N/A -1,282.05%
Dec 31, 2019 -0.37 -0.39 N/A 512.82%
Sep 30, 2019 -0.40 -0.38 N/A -526.32%
Jun 30, 2019 -0.36 -0.33 N/A -909.09%
Mar 31, 2019 -0.30 -0.24 N/A -2,500.00%
Dec 31, 2018 -0.25 -0.24 N/A -416.67%
Sep 30, 2018 -0.31 -0.25 N/A -2,400.00%
Jun 30, 2018 -0.37 -0.32 N/A -1,562.50%
Mar 31, 2018 -0.27 -0.22 N/A -2,272.73%
Dec 31, 2017 -0.29 -0.24 N/A -2,083.33%
Sep 30, 2017 -0.26 -0.24 N/A -833.33%
Jun 30, 2017 -0.23 -0.24 N/A 416.67%
Mar 31, 2017 -0.24 -0.20 N/A -2,000.00%
Dec 31, 2016 -0.21 -0.29 N/A 2,758.62%
Sep 30, 2016 -0.27 -0.28 N/A 357.14%
Jun 30, 2016 -0.29 -0.31 N/A 645.16%
Mar 31, 2016 -0.29 -0.25 N/A -1,600.00%
Dec 31, 2015 -0.26 -0.27 N/A 370.37%
Sep 30, 2015 -0.24 -0.30 N/A 2,000.00%
Jun 30, 2015 -0.33 -0.39 N/A 1,538.46%
Mar 31, 2015 -0.38 -0.36 N/A -555.56%
Dec 31, 2014 -0.30 -0.31 N/A 322.58%
Sep 30, 2014 -0.30 -0.33 N/A 909.09%
Jun 30, 2014 -0.30 -0.37 N/A 1,891.89%
Mar 31, 2014 -0.34 -0.33 N/A -303.03%
Dec 31, 2013 -0.29 -0.27 N/A -740.74%
Sep 30, 2013 -4.81 -0.32 N/A -140,312.50%

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $36.06M $N/A $440.69M $121.97M $318.73M
2023-12-31 $41.87M $N/A $506.22M $137.80M $368.42M
2022-12-31 $61.33M $N/A $705.56M $221.62M $483.94M
2021-12-31 $133.58M $N/A $921.46M $242.62M $678.84M
2020-12-31 $167.35M $N/A $622.46M $238.01M $384.45M
2019-12-31 $99.81M $N/A $302.27M $57.52M $244.76M
2018-12-31 $190.51M $N/A $213.03M $52.56M $160.47M
2017-12-31 $88.95M $N/A $105.29M $28.10M $77.19M
2016-12-31 $88.61M $N/A $95.05M $21.89M $73.15M
2015-12-31 $64.81M $N/A $67.96M $29.92M $38.04M
2014-12-31 $49.10M $N/A $51.20M $22.86M $28.34M
2013-12-31 $54.04M $N/A $55.58M $4.74M $50.85M
2012-12-31 $9.09M $N/A $11.08M $63.90M $-52.83M
2011-12-31 $6.39M $N/A $7.85M $58.54M $-50.68M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Aug 04, 2025 N/A N/A N/A N/A N/A N/A
Aug 04, 2025 N/A N/A N/A N/A N/A N/A
Jan 10, 2025 N/A N/A N/A N/A N/A N/A
Jan 10, 2025 N/A N/A N/A N/A N/A N/A
Dec 20, 2024 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist